
### [MONDO:0017393](http://purl.obolibrary.org/obo/MONDO_0017393)
**Label:** blepharophimosis-intellectual disability syndrome

**Subclasses:** [MONDO:0017996](http://purl.obolibrary.org/obo/MONDO_0017996) (blepharophimosis-intellectual disability syndrome due to UBE3B deficiency), [MONDO:0011365](http://purl.obolibrary.org/obo/MONDO_0011365) (blepharophimosis-intellectual disability syndrome, SBBYS type), [MONDO:0009583](http://purl.obolibrary.org/obo/MONDO_0009583) (blepharophimosis-intellectual disability syndrome, Ohdo type), [MONDO:0010477](http://purl.obolibrary.org/obo/MONDO_0010477) (blepharophimosis-intellectual disability syndrome, MKB type), [MONDO:0000734](http://purl.obolibrary.org/obo/MONDO_0000734) (Ohdo syndrome and variants), [MONDO:0011432](http://purl.obolibrary.org/obo/MONDO_0011432) (blepharophimosis-intellectual disability syndrome, Verloes type), [MONDO:0013424](http://purl.obolibrary.org/obo/MONDO_0013424) (3p- syndrome), 

**Mapped go classes:** [GO:0016569](http://purl.obolibrary.org/obo/GO_0016569) (covalent chromatin modification), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0033100](http://purl.obolibrary.org/obo/GO_0033100) (NuA3 histone acetyltransferase complex), [GO:0007492](http://purl.obolibrary.org/obo/GO_0007492) (endoderm development), [GO:0021954](http://purl.obolibrary.org/obo/GO_0021954) (central nervous system neuron development), [GO:0001105](http://purl.obolibrary.org/obo/GO_0001105) (RNA polymerase II transcription coactivator activity), [GO:0001104](http://purl.obolibrary.org/obo/GO_0001104) (RNA polymerase II transcription cofactor activity), [GO:0002761](http://purl.obolibrary.org/obo/GO_0002761) (regulation of myeloid leukocyte differentiation), [GO:0032968](http://purl.obolibrary.org/obo/GO_0032968) (positive regulation of transcription elongation from RNA polymerase II promoter), [GO:0000781](http://purl.obolibrary.org/obo/GO_0000781) (chromosome, telomeric region), [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0018394](http://purl.obolibrary.org/obo/GO_0018394) (peptidyl-lysine acetylation), [GO:0000183](http://purl.obolibrary.org/obo/GO_0000183) (chromatin silencing at rDNA), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001822](http://purl.obolibrary.org/obo/GO_0001822) (kidney development), [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0016573](http://purl.obolibrary.org/obo/GO_0016573) (histone acetylation), [GO:0051726](http://purl.obolibrary.org/obo/GO_0051726) (regulation of cell cycle), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette), [GO:0016239](http://purl.obolibrary.org/obo/GO_0016239) (positive regulation of macroautophagy), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0000786](http://purl.obolibrary.org/obo/GO_0000786) (nucleosome), [GO:0006334](http://purl.obolibrary.org/obo/GO_0006334) (nucleosome assembly), [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development), [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0034212](http://purl.obolibrary.org/obo/GO_0034212) (peptide N-acetyltransferase activity), [GO:0043967](http://purl.obolibrary.org/obo/GO_0043967) (histone H4 acetylation), [GO:0016746](http://purl.obolibrary.org/obo/GO_0016746) (transferase activity, transferring acyl groups), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0035267](http://purl.obolibrary.org/obo/GO_0035267) (NuA4 histone acetyltransferase complex), [GO:0016747](http://purl.obolibrary.org/obo/GO_0016747) (transferase activity, transferring acyl groups other than amino-acyl groups), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation), [GO:0001207](http://purl.obolibrary.org/obo/GO_0001207) (histone displacement), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0006348](http://purl.obolibrary.org/obo/GO_0006348) (chromatin silencing at telomere), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:1990467](http://purl.obolibrary.org/obo/GO_1990467) (NuA3a histone acetyltransferase complex), [GO:1990468](http://purl.obolibrary.org/obo/GO_1990468) (NuA3b histone acetyltransferase complex), [GO:0016592](http://purl.obolibrary.org/obo/GO_0016592) (mediator complex), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006354](http://purl.obolibrary.org/obo/GO_0006354) (DNA-templated transcription, elongation), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0008013](http://purl.obolibrary.org/obo/GO_0008013) (beta-catenin binding), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0032777](http://purl.obolibrary.org/obo/GO_0032777) (Piccolo NuA4 histone acetyltransferase complex), [GO:0010485](http://purl.obolibrary.org/obo/GO_0010485) (H4 histone acetyltransferase activity), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [GO:0090202](http://purl.obolibrary.org/obo/GO_0090202) (gene looping) 52.27%
- [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping) 52.27%
- [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis) 52.27%
- [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis) 52.27%
- [GO:0043583](http://purl.obolibrary.org/obo/GO_0043583) (ear development) 52.27%
- [GO:0035138](http://purl.obolibrary.org/obo/GO_0035138) (pectoral fin morphogenesis) 52.27%
- [GO:0035118](http://purl.obolibrary.org/obo/GO_0035118) (embryonic pectoral fin morphogenesis) 52.27%
- [GO:0030901](http://purl.obolibrary.org/obo/GO_0030901) (midbrain development) 52.27%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 52.27%
- [GO:0030466](http://purl.obolibrary.org/obo/GO_0030466) (chromatin silencing at silent mating-type cassette) 52.27%
- [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development) 52.27%
- [GO:0021982](http://purl.obolibrary.org/obo/GO_0021982) (pineal gland development) 52.27%
- [GO:0021654](http://purl.obolibrary.org/obo/GO_0021654) (rhombomere boundary formation) 52.27%
- [GO:0021591](http://purl.obolibrary.org/obo/GO_0021591) (ventricular system development) 52.27%


